Novel design for a phase IIa placebo-controlled, double-blind randomized withdrawal study to evaluate the safety and efficacy of CNV1014802 in patients with trigeminal neuralgia
Gespeichert in:
Verfasser / Beitragende:
[Joanna M Zakrzewska, Joanne Palmer, Dominik A Ettlin, Mark Obermann, Gerard M P Giblin, Valerie Morisset, Simon Tate, Kevin Gunn]
Ort, Verlag, Jahr:
2013
Enthalten in:
Trials, 14:402
Format:
Artikel (online)
Online Zugang: